Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus

NCT00406549 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-10-02

No results posted yet for this study

Summary

To establish the clinical test performance characteristics of sensitivity, specificity and predictive values for direct detection of nasal Staphylococcus aureus colonization against clinical microbiology laboratory culture methods.

Conditions

  • Staphylococcus Aureus

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY
  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Steve Gordon, M.D. · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Completion
2007-03-31

Countries

  • United States
  • France
  • Germany
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00406549 on ClinicalTrials.gov